Cipla has received final USFDA approval for Medroxyprogesterone injectable for prevention of pregnancy in the markets of America. The injection Medroxyprogesterone injectable 150mg/million is a […]
Dr Reddy’s Laboratories Ltd has received USFDA approval for ‘Tosymra’ spray which is used to treat acute migraine with or without aura in adults. The […]
Wockhardt has received final USFDA approval for 100 mg and 400 mg tablets of Imatinib Mesylate to market the same in US markets. The drug […]
Zydus Cadila has received the final USFDA approval to market Acetazolamide ER Capsules. Acetazolamide is a potent carbonic anhydrase inhibitor. Acetazolamide ER capsules are used […]
Lupin has received final USFDA approval for Levothyroxine Sodium tablets USP, 25 mcg, 50 mcg, 75 mcg, 88 mcg, 100 mcg, 112 mcg, 125 mcg, […]
Shilpa Medicare has received final USFDA approval for Irinotecan HCL injection to market the same in US. The injection drug will be marketed in the […]
Alembic Pharmaceuticals has received final USFDA approval for Pramipexole Dihydrochloride extended-release tablets used for the treatment of Parkinson’s disease. The drug will be marketed in […]
Cadila has received final USFDA approval to market antipsychotic drug Aripiprazole tablets in US markets. The drug will be marketed in the strengths of 2 […]
Lupin has received USFDA approval to market Lurasidone Hydrochloride tablets in US markets. The drug is used in the treatment of schizophrenia and will be […]
Aurobindo Pharma Ltd has received USFDA approval to market potassium chloride tablets of 600 mg and 750 mg in the US market. The tablet, a […]
Copyright © 2024 | WordPress Theme by MH Themes